cytarabine and Neuroectodermal Tumors, Primitive, Peripheral

cytarabine has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albright, AL; Allen, JC; Boyett, JM; Finlay, JL; Geyer, JR; Milstein, JM; Rorke, LB; Stanley, P; Wisoff, JH; Zeltzer, PM1

Other Studies

1 other study(ies) available for cytarabine and Neuroectodermal Tumors, Primitive, Peripheral

ArticleYear
Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Ependymoma; Female; Humans; Hydroxyurea; Infant; Male; Neuroectodermal Tumors, Primitive, Peripheral; Prednisone; Procarbazine; Survival Analysis; Vincristine

1994